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O B J E C T I V E S The aim of this study was to examine the value of native and post-contrast T1
relaxation in the differentiation between healthy and diffusely diseased myocardium in 2 model
conditions, hypertrophic cardiomyopathy and nonischemic dilated cardiomyopathy.
B A C KG ROUND T1 mapping has been proposed as potentially valuable in the quantitative
assessment of diffuse myocardial ﬁbrosis, but no studies to date have systematically evaluated its role
in the differentiation of healthy myocardium from diffuse disease in a clinical setting.
METHOD S Consecutive subjects undergoing routine clinical cardiac magnetic resonance at King’s
College London were invited to participate in this study. Groups were based on cardiac magnetic
resonance ﬁndings and consisted of subjects with known hypertrophic cardiomyopathy (n  25) and
nonischemic dilated cardiomyopathy (n 27). Thirty normotensive subjects with low pre-test likelihood
of cardiomyopathy, not taking any regular medications and with normal cardiac magnetic resonance
ﬁndings including normal left ventricular mass indexes, served as controls. Single equatorial short-axis
slice T1 mapping was performed using a 3-T scanner before and at 10, 20, and 30 minutes after the
administration of 0.2 mmol/kg of gadobutrol. T1 values were quantiﬁed within the septal myocardium
(T1native), and extracellular volume fractions (ECV) were calculated.
R E S U L T S T1native was signiﬁcantly longer in patients with cardiomyopathy compared with control
subjects (p  0.01). Conversely, post-contrast T1 values were signiﬁcantly shorter in patients with
cardiomyopathy at all time points (p  0.01). ECV was signiﬁcantly higher in patients with cardiomyopathy
compared with controls at all time points (p  0.01). Multivariate binary logistic regression revealed that
T1native could differentiate between healthy and diseased myocardium with sensitivity of 100%, speciﬁcity of
96%, and diagnostic accuracy of 98% (area under the curve 0.99; 95% conﬁdence interval: 0.96 to 1.00; p 
0.001), whereas post-contrast T1 values and ECV showed lower discriminatory performance.
CONC L U S I O N S This study demonstrates that native and post-contrast T1 values provide indexes with
high diagnostic accuracy for the discrimination of normal and diffusely diseasedmyocardium. (J Am Coll Cardiol
Img 2013;6:475–84) © 2013 by the American College of Cardiology Foundation
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476yocardial fibrosis is a fundamental pro-
cess in the development of myocardial
dysfunction in various cardiomyopa-
thies, leading to myocardial remodeling
nd poor outcomes (1–5). Cardiac magnetic reso-
ance (CMR) is increasingly applied as the first-
ine investigation into the causes of cardiomyopa-
hies (6). Visualization of fibrosis by CMR is based
n a greater distribution volume and slower wash-
ut of gadolinium contrast agents within tissues
ith greater extracellular space due to edema or
brosis (7). Whereas regional fibrosis after ischemic
See page 485
injury is readily distinguished by well-delineated areas
of increased signal intensity on T1-weighted images
by late gadolinium enhancement (LGE) (8), it may be
impossible to define an area of clearly unaffected
myocardium as a “nulled” reference in diffuse
fibrotic processes (Figs. 1A and 1B) (9). As
a consequence, such images may null the
signal in areas of fibrosis, obscuring the
finding or result in images with various gray
values, not allowing a clear “yes or no”
decision (9,10). Recently, several studies
have proposed the measurement of T1 re-
laxation as potentially valuable for the quan-
titative assessment of myocardial fibrosis
(11–16). In these studies, native myocar-
dium with ischemic scar showed longer T1
values compared with unaffected remote
myocardium. After contrast administration,
regional and also diffusely scarred myocar-
dium showed shorter T1 relaxation and
elayed normalization of T1 times with gadolinium
ashout. Whereas these observations show the poten-
ial of T1 mapping for the evaluation of myocardial
brosis, these studies used a variety of imaging meth-
dologies and post-processing approaches. The ability
f T1 mapping to differentiate between normal and
bnormal myocardium is yet to yield a clinically robust
pplication. In the present study, we aimed to
xamine the value of native and post-contrast T1
elaxation in the differentiation of healthy and
iffusely diseased myocardium in 2 model condi-
ions, hypertrophic cardiomyopathy (HCM) and
onischemic dilated cardiomyopathy (NIDCM).
M E T H O D S
Consecutive subjects undergoing routine clinical
CMR at King’s College London were invited toparticipate in this study. Groups were based on CMR
findings and consisted of subjects with known HCM
(n  25) and NIDCM (n  27) and controls (n 
0). Diagnosis of HCM was based on the demonstra-
ion of a hypertrophied left ventricle associated with a
ondilated left ventricle (LV) in the absence of in-
reased LV wall stress or another cardiac or systemic
isease that could result in a similar magnitude of
ypertrophy (17,18). All patients with HCM had an
xpressed phenotype with typically asymmetric septal
ypertrophy of increased LV wall thickness, permit-
ing unequivocal clinical diagnoses. NIDCM was
efined as an increase in LV volumes, a reduction in
lobal systolic function, and absence of evidence of
schemic-like LGE (18). Thirty normotensive sub-
ects with low pre-test likelihood for LV cardiomyop-
thy, not taking any regular medications and, conse-
uently, with normal CMR findings including normal
V mass indexes, served as the control group (19).
dditional exclusion criteria for all subjects were the
enerally accepted contraindications to CMR (im-
lantable devices, cerebral aneurysm clips, cochlear
mplants, severe claustrophobia) or a history of renal
isease with a current estimated glomerular filtration
ate 30 ml/min/1.73 m2. The study protocol was
eviewed and approved by the institutional ethics
ommittee, and written informed consent was ob-
ained from all participants.
CMR protocol. We integrated native and post-contrast
yocardial T1 mapping into our routine imaging
rotocol for the determination of the underlying
tiology of cardiomyopathy; an outline is provided in
igure 2. The CMR studies were performed with the
atient supine, using a clinical 3-T scanner (Achieva
X, Philips Healthcare, Best, the Netherlands) and a
2-channel coil. After standardized patient-specific
lanning (20), volumetric cavity assessment was ob-
ained by whole-heart coverage of gapless short-axis
lices. Thereafter, cine images of 3 long-axis views
4-chamber, 2-chamber, and 3-chamber views) and
ransverse axial views were acquired. All cine-images
ere acquired using a balanced steady-state free pre-
ession sequence in combination with parallel imaging
SENSitivity Encoding, factor 2) and retrospective
ating during a gentle expiratory breath-hold (echo
ime [TE]/repetition time [TR]/flip-angle: 1.7 ms/
.4 ms/60°, spatial resolution 1.8  1.8  8 mm).
LGE imaging was performed in a gapless whole heart
coverage of short axis slices 20 min after administra-
tion of a cumulative dose of 0.2 mmol/kg body weight
gadobutrol using a mid-diastolic inversion prepared
2-dimensional gradient echo sequence (TE/TR/flip-A B B R E V I A T I O N S
A N D A C R O N YM S
CI confidence interval
CMR cardiac magnetic
resonance
HCM hypertrophic
cardiomyopathy
HR heart rate
LGE late gadolinium
enhancement
LV left ventricular
NIDCM nonischemic
dilated cardiomyopathyangle 2.0 ms/3.4 ms/25°, interpolated voxel size 0.7
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477Figure 1. Examples of LGE Images in Conditions With Diffuse Myocardial Involvement
Look-Locker images and late gadolinium enhancement (LGE) images in burnt-out hypertrophic cardiomyopathy (A) and dilated cardio-
myopathy after previous myocarditis (B). There was a reduced overall relative difference in signal between affected and unaffected myo-
cardium in Look-Locker images, leading to difﬁculty in nulling of the normal myocardium. 4CH  4-chamber; SAX  short-axis; 3CH 
3-chamber; 2CH  2-chamber.
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4780.7 8 mm, and a patient-adapted prepulse delay, as
appropriate. A steady-state free precession, single-
breath-hold modified Look-Locker inversion re-
covery sequence was used for T1 mapping, per-
formed in an equatorial short-axis slice before
and at 10, 20, and 30 min after contrast admin-
istration. Imaging parameters were as follows: field of
view 320  320, TR 3.3 ms, TE 1.57 ms, flip angle
50°, interpolated voxel size 0.9  0.9  8 mm, 166
phase-encoding steps, heart rate (HR)–adapted trig-
ger delay, 11 phases (3  3  5), and adiabatic
pre-pulse to achieve a complete inversion (14–16).
Image analysis. All routine CMR analysis was per-
ormed using commercially available software (View-
orum, Extended Workspace, Philips Healthcare).
ndocardial LV borders were manually traced at
nd-diastole and end-systole. The papillary muscles
ere included as part of the LV cavity volume. LV
nd-diastolic and end-systolic volumes were deter-
ined using Simpson’s rule. Ejection fraction was
omputed as end-diastolic volume  end-systolic
olume/end-diastolic volume. All volumetric indexes
ere normalized to body surface area.
The LGE images were visually examined for the
resence of regional fibrosis. Global enhancement was
efined as percent of enhanced area per total short-
xis stack, where enhanced area was defined by 6 SDs
bove the manually selected normal area, appearing as
aximally suppressed myocardium (10).
T1 relaxation maps were obtained using Relax-
aps tools supported by the PRIDE environment
Philips Healthcare). Selective acquisition at a fixed
oint of the cardiac cycle in end-diastole largely
uppressed the influence of cardiac motion, but the
Start
Start
Native T1 T110min T120min T130min
Planning Short-axis
Stack
Transverse
Stack
Scar
Imaging
EndContrast Injection
Figure 2. Integration of MOLLI Sequences in Clinical Routine
Modiﬁed Look-Locker inversion recovery (MOLLI) sequences were inte-
grated into the clinical protocol for the investigation of cardiomyopa-
thy, with set spacing between the time points. Time points denote the
interval from gadolinium contrast administration.elatively long duration of the sequence (17 heartbeatso obtain a single slice map) occasionally led to some
ndesired breathing motion. We therefore performed
motion correction image preparation step using a
ustom-made tool developed in house on the basis of
hierarchical adaptive local affine registration tech-
ique, as previously described (21), in which a refer-
nce phase (source) is registered to each of the selected
arget phases (11 in total). A rectangular region of
nterest (ROI) large enough to enclose the whole of
he LV is manually drawn onto the source reference
hase before registration. After the initial image affine
egistration step of the ROI, the source image is
ubdivided into 4 smaller ROIs using equal subdivi-
ions. Each subdivision underwent an affine transfor-
ation again (each with 6 degrees of freedom) to align
he features of the target image ROIs with the
orresponding ROIs in the source phase image.
oregistered images were then used to derive T1
alues. Because previous studies showed substantial
egmental variation in T1 values, which was greatest
n lateral and smallest in the septal segments (15,16),
n interobserver consensus was reached to place the
OIs within the septal myocardium (Figs. 3 and 4).
are was also taken to avoid “contamination” with
ignal from the blood pool. Reported T1 values were
erived blinded to the LGE images to enable high
nterobserver and intraobserver reproducibility of T1
easurements. We additionally examined the influ-
nce of visualized LGE on the T1 values, regionally
Figure 3. T1 Map With Color Scale and Region of Interest
With interobserver consensus, the region of interest was placed
conservatively within the septal myocardium. Care was also taken
to avoid “contamination” with signal from the blood pool.
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479and within the septal ROIs. T1 was determined
by fitting a 3-parameter exponential model to the
measured data and applying Look-Locker correc-
tion, as previously described (14). Noise was calcu-
lated in an ROI drawn manually inside the lungs
and taken into account in the T1 computation (22).
Because longitudinal relaxation is HR dependent,
we also applied HR correction of T1 values when
HR exceeded 80 beats/min, as previously described
(14,16). In addition to the T1 values of myocardium and
blood pool, we calculated volume fraction of extravascular
extracellular matrix (ECV) according to the formula
(22–25) ECV  [lambda  (1  hematocrit)], where
CV is the myocardial extravascular extracellular
olume fraction, and lambda  [R1myocardium]/
R1bloodpool] before and after gadolinium contrast
where R1  1/T1).
Statistical analysis. Statistical analysis was per-
ormed using SPSS version 20 (SPSS, Inc., Chi-
ago, Illinois). Differences from the control group
nd between the groups were examined using one-
ay and repeated-measures analysis of variance
ith Bonferroni post hoc tests, as appropriate.
eproducibility and agreement analysis was per-
ormed using paired Student t tests and bivariate
correlations. Associations with demographic and
hemodynamic variables were detected by bivariate
linear regression analyses. Multivariate binary logis-
tic regression was used to test the ability of T1-
Figure 4. Representative Images of Modiﬁed Look-Locker Inver
The region of interest was placed conservatively within the septal m
pool. Blood T1 values were obtained by placing the region of interderived measures in discrimination between healthyand abnormal myocardium. The sensitivity, speci-
ficity, and diagnostic accuracy, areas under the
curve, and cutoff values were derived using receiver-
operating characteristic curve analysis using the
point that maximized the trade-off between speci-
ficity and sensitivity. Z-scores were used to compare
the areas under the curve. All tests were 2 tailed,
and p values 0.05 were considered significant.
R E S U L T S
Patients’ characteristics, hemodynamic variables,
and cardiac function are presented in Table 1. All
groups had similar sex representations, HRs, and
body surface areas. In comparison with controls,
patients with HCM had increased global systolic
function and diastolic LV wall thickness (p 0.01).
Compared with controls, subjects with NIDCM
had increased cavity volumes and reduced global
systolic function (p  0.01). Both patient groups
had increased LV mass index (p  0.01). Eighteen
patients with HCM and 9 with NIDCM had
evidence of LGE on scar imaging, as patchy LGE
or intramyocardial stria.
T1 of myocardium and blood pool and ECV. T1 values
of blood pool were similar between the groups. T1
of native myocardium (T1native) was significantly
onger in cardiomyopathies compared with control
ubjects (p  0.01) (Table 2). Conversely, post-
Recovery Imaging
cardium to avoid “contamination” with signal from the blood
n the center of the ventricular lumen. SI  signal intensity.sion
yocontrast T1 values were significantly shorter in the
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480presence of cardiomyopathy at all time points (p 
.01). Similarly, lambda values were significantly
igher in patients with cardiomyopathy in compar-
son with controls (p  0.01). ECV values were
acteristics and Global Morphological and Functional Measures
Controls Patients With HCM Patients With NIDCM
(n  30) (n  25) (n  27)
19 (63) 16 (64) 18 (67)
43 9 44 11 45 14
113 6 115 6 120 6
69 8 72 6 75 10
64 10 66 9 66 9
2 24 3 24 3 23 4
76 9 70 10 110 15*
63 6 72 8† 34 6*
55 8 99 10* 106 11*
9 2 18 2* 10 2
6 5 12 11* 10 8†
82 10 83 9 74 12
44 3 43 3 43 2
SD. *p 0.01 (Bonferroni post-hoc tests for differences from the control group)
R  estimated glomerular ﬁltration rate; HCM  hypertrophic cardiomyopathy;
eft ventricular; LVEDV  left ventricular end-diastolic volume; LVWT  left
NIDCM  nonischemic dilated cardiomyopathy.
Table 2. Native and Post-Contrast T1 Relaxation Times
Controls
(n  30)
Native
T1 myocardium, ms 1,070 55
T1 blood, ms 1,871 89
R1 myocardium, ms1  105 94 4
10 min
T1 myocardium, ms 402 58
T1 blood, ms 247 34
R1 myocardium, ms1  105 254 40
Lambda 0.46 0.13
ECV 0.27 0.1
20 min
T1 myocardium, ms 440 58
T1 blood, ms 294 32
R1 myocardium, ms1  105 230 31
Lambda 0.49 0.12
ECV 0.27 0.09
30 min
T1 myocardium, ms 504 38
T1 blood, ms 381 42
R1 myocardium, ms1  105 199 14
Lambda 0.47 0.09
ECV 0.26 0.07
*p  0.01 (Bonferroni post-hoc tests for differences from the control group) an
ECV  extracellular volume; other abbreviations as in Table 1.similar at all time points for the total cohort (10 vs.
20 vs. 30 min: 28  11 vs. 29  10 [p  0.35] vs.
27  9 [p  0.22]). ECV in patients was signifi-
cantly higher compared with controls at all time
points (p  0.01).
There were no significant differences in mean T1
values between subjects with visually detectable LGE
and those without it (T1native: HCM, 1,241 51 ms vs.
1,234 71 ms, p 0.88, NIDCM, 1,290 52 ms vs.
,301 49 ms, p 0.58; T120min: HCM, 367 42 ms
vs. 361 39 ms, p 0.91, NIDCM, 346 43 ms vs.
358 48 ms, p 0.60). Regions of visualized LGE
howed no significant difference from the septal
OI T1 values for T1native and T120min maps
(T1native septal ROI vs. regional ROI mean difference
2.7 9.4, p 0.91; T120min mean difference1.9
3, p  0.92).
Reproducibility and agreement analysis. In a subset
of subjects (n  47), interobserver mean differences
or T1 values were 1.3 ms (95% confidence interval
CI]:12.4 to 15.4 ms) for native scans and 0.7 ms
95% CI: 7.9 to 12.3 ms) for overall post-contrast
cans, whereas intraobserver mean differences were
.3 ms (95% CI: 6.3 to 5.3) and 0.1 ms (95%
I: 3.4 to 4.2), respectively. We demonstrate
Patients With HCM Patients With NIDCM
(n  25) (n  27)
1,254 43* 1,239 57*
1,869 92 1,901 92
80 4* 76 4*
307 47* 296 43*
251 39 245 38
339 44* 345 41*
0.72 0.18* 0.70 0.18*
0.40 0.1* 0.41 0.1*
363 63* 355 44*
299 36 297 33
284 50* 284 30*
0.73 0.2* 0.73 0.09*
0.41 0.12* 0.40 0.09*
437 49† 444 45†
369 37 351 45
230 20* 227 23*
0.67 0.10* 0.67 0.12*
0.38 0.11* 0.38 0.1*
 0.05.Table 1. Patient Char
Men
Age, yrs
Systolic BP, mm Hg
Diastolic BP, mm Hg
HR, beats/min
Body mass index, kg/m
LVEDV index, ml/m2
LV ejection fraction, %
LV mass index, g/m2
Maximal LVWT, mm
Global enhancement, %
eGFR, ml/min/1.73 m2
Hematocrit, %
Values are n (%) or mean
and †p  0.05.
BP  blood pressure; eGF
HR  heart rate; LV  ld †p
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481excellent overall (pre-contrast and post-contrast)
intraobserver and interobserver agreement in T1
values (intraobserver: r  0.99, p  0.0001; inter-
observer: r  0.98, p  0.0001).
Comparisons of T1measures in discrimination between
normal and abnormal myocardium. In multivariate
inary logistic regression model using native and
ost-contrast T1 and ECV values, we identified
1native as the independent discriminator of cardio-
yopathic myocardium (p  0.001), with sensitiv-
ty of 100%, specificity of 96%, diagnostic accuracy
f 98%, a positive predictive value of 98%, and a
egative predictive value of 100%. Comparison of
reas under the curve showed that T1native provided
he best distinction between controls and patients
ith cardiomyopathy (T1native vs. T10min: z  2.2,
 0.05; T1native vs. ECV20min: z 2.4, p 0.02).
Results of receiver-operating characteristic curve
analysis with corresponding cutoff values for the
performance of separate T1-derived measures in the
differentiation of normal from abnormal myocar-
dium are presented in Table 3 and Figure 5.
Analysis of relationships. Within the separate patient
groups, there was a positive association between
T1native and ECV and age (T1native: r  0.53, p 
.03; ECV: r  0.51, p  0.05). In controls and
patients with NIDCM, myocardial T1native showed
egative associations with indexed LV end-diastolic
olume (r  0.37 and 0.54, respectively, p  0.05).
Patients with NIDCM showed further associations
between myocardial T1native and ejection fraction
(r0.61, p 0.01), whereas in patients with HCM,
there was a positive association between myocardial
T1native and indexed LV mass (r  0.51, p  0.01).
D I S C U S S I O N
Our study reveals that diffusely diseased myocar-
Table 3. Results of Cutoff Values on Receiver-Operating Charac
Cutoff
Value
AUC
(95% CI)
Signiﬁcan
(p Value
T1 value, ms
Native 1,184 0.99 (0.98–1.00) 0.000
10 min 330 0.90 (0.87–0.97) 0.000
20 min 407 0.86 (0.79–0.96) 0.000
30 min 477 0.84 (0.74–0.96) 0.000
ECV
ECV10min 23 0.86 (0.76–0.95) 0.000
ECV20min 23 0.85 (0.77–0.95) 0.000
ECV30min 23 0.88 (0.80–0.96) 0.000
AUC  area under the curve; CI  conﬁdence interval; other abbreviations asdium can be reliably differentiated from healthymyocardium by means of T1 mapping. We dem-
onstrate that in HCM and NIDCM, native and
post-contrast T1 values provide indexes with high
diagnostic accuracy, sensitivity, and specificity, with
T1native providing the greatest distinction between
ealthy and diffusely diseased myocardium. We
urther demonstrate that in NIDCM, T1native cor-
relates with measures of LV remodeling and global
systolic function, whereas in HCM, it shows an
association with indexed LV mass. Our findings
provide a novel and easy-to-use method for the
detection of diffusely diseased myocardial tissue by
CMR with an immediate potential for clinical
translation.
T1 mapping techniques provide quantifiable in-
formation on longitudinal relaxation through the
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482acquisition of images with different inversion times
and by multiparametric curve-fitting analysis. T1
maps are derived as parametric reconstructed im-
ages, in which the signal intensity of a pixel depends
on the absolute longitudinal relaxation properties of
this voxel (13–16,22). Several methodologies were
tested to acquire the myocardial T1 relaxation
values, including sets of saturation or inversion
recovery images (12) with varying inversion times
and, lately, the classical and modified Look-Locker
sequences (14–16,23). The variant of the latter
sequence, which was also applied in the present
study, leads to a series of multiple images acquired
within the same phase of cardiac cycle through a
selective fixed delay time over successive heartbeats
(14). Some studies using this or related methodol-
ogies suggested that myocardial T1native values
could be used to discern post-infarct scar from
healthy myocardium (15,16). Most of these studies,
however, focused on the post-contrast T1 values
and reported significantly shorter T1 times com-
pared with controls. In a population of patients with
mixed causes of heart failure, Iles et al. (12) reported
shorter post-contrast T1 compared with controls,
even when excluding areas of regional fibrosis.
These investigators also observed an inverse rela-
tionship between post-contrast T1 values and the
amount of fibrosis on histology (12). The ability of
T1 imaging to quantify the amount of diffuse
fibrosis was also confirmed using a novel technique
of ECV imaging deriving ECV using continuous
infusion (24,25). Diastolic myocardial impairment,
an indirect marker of diffuse myocardial fibrosis,
was shown to correlate with abnormal post-contrast
T1 values in patients with heart failure, diabetic
cardiomyopathy, and amyloidosis (11,26 –28).
Whereas Iles et al. (12) showed no significant
difference in myocardial T1native values in patients
ith heart failure, our findings reveal for the first
ime that native T1 values are significantly higher in
iffusely disease myocardium, which cannot be
ccounted for by the presence of visualized LGE.
he disparity with the former findings may lie in
he differences in patient selection, as well as imag-
ng techniques and higher field strength used in the
resent study, which explains higher measurements
f longitudinal relaxation in native myocardium
15,16,29).
In our study, myocardial T1native provides the
reatest distinction between healthy myocardium
nd diseased tissue with high negative predictive
alue. As such, it bears potential for the develop-
ent of an easy-to-implement test in patients withuspected diffuse fibrosis, which may be missed by
lassic LGE imaging. Furthermore, in subjects with
ow pre-test likelihood for the presence of cardio-
yopathy (descriptive of our control group), or
hose in whom contrast administration is contraindi-
ated, it may serve as an effective screening test. Future
dvances in sequence development that would provide
hole-heart coverage might derive a useful approach
o characterize regional differences and potentially
bviate the need for contrast administration.
The observed findings in myocardial T1native
emphasize several important aspects with regard to
post-contrast T1 mapping. Because gadolinium
administration greatly shortens T1 values, the over-
all T1 tissue relaxation will depend on the dose and
relaxivity of the gadolinium contrast agent, the
intrinsic T1 values of the tissue (13,23,29), and the
timing of the acquisition and bioavailability after
gadolinium administration (7,9). Post-contrast T1
sampling can thus be affected by a variety of
independent variables, including renal function,
contrast type and dose of administration, variation
in sampling time points, and individual pharmaco-
kinetics (22,30). Post-contrast T1 imaging at the
rigid time points can prove cumbersome in clinical
routine; we improved the interstudy comparability
of the post-contrast T1 sampling by using consis-
tent time points in our routine cardiomyopathy
imaging protocol. Yet the aforementioned influ-
ences might explain the lower performance of
post-contrast T1 values and ECV.
In our study, T1 values were sampled in 2 model
conditions of diffuse myocardial fibrosis. Whereas
several investigators have looked at the role of T1
mapping in patients with heart failure, no previous
study has systematically assessed native and post-
contrast T1 values in patients with HCM. It is well
established that visualization of LGE in HCM has
important and independent prognostic implications
(5), but recent evidence suggests that a profibrotic
state through genetically driven collagen metabo-
lism precedes the overt phenotype with LV hyper-
trophy or fibrosis visible on LGE (4). We previ-
ously demonstrated that global enhancement
correlates with reduction of longitudinal ventricular
deformation in HCM, even when global systolic
function remains apparently unaffected (10).
Whether T1-derived measures are able to detect
subclinical change in collagen metabolism remains
to be determined. The identification of early phe-
notypes in which early fibrotic process could be
quantified and followed up before the effects on
b
t
l
K
I
S
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 6 , N O . 4 , 2 0 1 3
A P R I L 2 0 1 3 : 4 7 5 – 8 4
Puntmann et al.
Native T1 Mapping and Diffuse Myocardial Fibrosis
483cardiac geometry and function would add to the
management of this condition (4).
The observed changes in post-contrast T1 values
have been previously related to increase in extracel-
lular space and well described in models of acute
and chronic ischemic or inflammatory myocardial
injury. The physiological correlate with diffuse
myocardial pathology and observed increases in
native T1 is less well understood. Extracellular
matrix remodeling is orchestrated by fibroblasts
within the heart, but changes in extracellular
matrix composition affect cardiomyocyte survival
(1–3,31). The accumulation of extracellular ma-
trix in pathological hypertrophy or LV remodel-
ing with increasing age and LV mass may under-
lie the observed increase in myocardial T1native
values (1). Further studies are needed to elucidate
the links between exact molecular mechanisms in
health and disease and the corresponding T1native
readouts.
Study limitations. The small sample size of other-
wise similar groups may limit the associations with
sex and age and generalization of the present
findings, and a larger multicenter study is required
to reconfirm our imaging protocol beyond the
proof of concept for widespread clinical use.
Examination of the equivalence of multivendor
sequences may also be appropriate. Next, T1
sampling in the septum of a single short-axis slice
is based on the assumption that it is representa-
tive of the diffuse myocardial process, but future
studies with multiple slices are needed to deter-
mine and understand relevant regional variation.
The prolonged acquisition time required for lon-
gitudinal relaxation to occur in the native myo-
cardium, especially at high field strengths, its HR
dependence, and motion artifacts may all amount
to errors in the pixel-wise estimation of T1 values
(32). Because we used motion and HR correction
algorithms and a very conservative approach toanalysis of cardiac extracellular matrix dicts major adverse evthe majority of these influences. Whether imag-
ing with shorter variants of modified Look-
Locker inversion recovery sequences would re-
solve some of the breathing motion artifacts and
still provide sufficient information on longitudi-
nal relaxation of the native myocardium remains
to be confirmed in future studies. Similarly, the
effects of T2 recovery when longitudinal relax-
ation is measured with modified Look-Locker
inversion recovery remain to be determined.
Whereas in the present study, we looked at 2
models of diffuse myocardial fibrosis, we assume
that the presence of edema and its influence on
T1 values is unlikely a relevant substrate. Lastly,
T1 values in other cardiomyopathies need to be
examined in future studies.
C O N C L U S I O N S
We demonstrate that native and post-contrast T1
values provide indexes with high diagnostic accu-
racy for the discrimination of normal and diffusely
diseased myocardium, as observed in patients with
HCM and NIDCM in the present study. Myocar-
dial T1native imaging provides the best distinction
etween controls and patients with cardiomyopa-
hy. Further studies are needed to effectively trans-
ate these findings into clinical use.
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